Company Oragenics Inc Nyse
Equities
US6840232036
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -71.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -71.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | 12-27 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 23-03-06 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 20-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 10-06-03 |
John Gandolfo
BRD | Director/Board Member | 63 | 23-10-03 |
Robert Koski
BRD | Director/Board Member | 65 | 09-06-29 |
Director/Board Member | 73 | 10-05-31 | |
Alan Dunton
BRD | Director/Board Member | 70 | 11-03-31 |
Bruce Cassidy
BRD | Director/Board Member | 74 | 23-10-03 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 20-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 7,488,692 | 0 | 0 | 76.77 % |
Stock B | 0 | 4,050,000 | 0 | 0 | |
Stock C | 1 | 4,480,693 | 3,439,769 ( 76.77 %) | 0 | |
Stock D | 0 | 5,417,000 | 0 | 0 |
Company contact information
Oragenics, Inc.
4902 Eisenhower boulevard Suite 125
33634-6310, Tampa
+813 286 7900
http://www.oragenics.com![address Oragenics Inc](https://cdn.zonebourse.com/static/address/12970117.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.98B | |
-24.33% | 19.27B | |
-19.35% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |